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Abstract  
Transcriptional profiling has revealed that Mycobacterium tuberculosis adapts both 
its metabolic and respiratory states during infection, utilising lipids as a carbon 
source and switching to alternative electron acceptors. These global gene 
expression datasets may be exploited to identify virulence determinants and to 
screen for new targets for rational drug design. Characterising the changing 
physiological predicament of distinct M.tb populations during infection will help 
expose the fundamental biology of M.tb; highlighting mechanisms that influence 
tuberculosis pathogenicity. 
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Introduction  
Mycobacterium tuberculosis (M.tb) is able to survive in multiple diverse surroundings 
during the infectious process; from intracellular environments permissive and non-
permissive for growth, to the extracellular milieu of heterogeneous lung lesions, to 
transmission by aerosol and the establishment of a new infection. Transcriptional 
profiling provides a global method for describing and modelling the adaptations 
necessary for M.tb survival in each scenario. The sequencing of the M.tuberculosis 
H37Rv genome [1] together with the development of mycobacterial RNA isolation [2-
4] and amplification [5] techniques has enabled genome-wide microarray profiling to 
be applied to tissue culture, animal model or natural M.tb infection settings. These 
intracellular and in vivo-derived M.tb transcriptional signatures, relative in most cases 
to log phase bacilli grown in axenic culture, capture key metabolic modifications and 
immune mediator expression that ultimately results in TB disease. This review 
focuses on the remodelling of the M.tb transcriptome during infection, highlighting 
the mechanisms of pathogenesis reflected therein. 
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M.tb populations captured by in vivo transcriptional profiling 
The considerable variation of parameters such as oxygen tension, pH or nutrient 
availability in the diverse intracellular and extracellular microenvironments 
encountered by M.tb during infection, together with stochastic host and pathogen 
interactions, likely results in a heterogeneous population of in vivo bacilli. This 
heterogeneity is reflected in the divergent transcriptional signatures of in vivo-derived 
M.tb [6-8]. The relative mRNA abundance measurements derived from gene 
expression analyses represent the average from the mixed populations of bacilli 
sampled. Furthermore, the experimentally determined transcriptional signature 
derived from a 70:30 combination of two phenotypically distinct populations 
(aerobically replicating:non-replicating persistence stage 2 bacilli) equates to the 
expected outcome using a simple additive model of gene expression [9]. The 
mechanistic insight or value for biomarker identification derived from the 
interpretation of these transcriptome datasets will therefore shift depending on the 
known bacterial heterogeneity in each scenario. Figure 1 summarises the broad and 
overlapping populations of bacilli that have been captured by gene expression 
profiling to date. The primary focus of research and the majority of mechanisms 
described in this review are based on observations derived from macrophage 
infection models due to the reasons described above, the relative low complexity of 
the system and because this is such a key step in mycobacterial pathogenesis. 
 
The fundamental transcriptional adaptations that M.tb undergoes in an intracellular 
setting are summarised in Figure 2. While the exact environmental cues and 
regulatory cascades are not yet clearly defined, it is likely that many of these 
5 
 
systems are interdependent as the insults of infection drive overlapping bacterial 
responses. 
 
Lipid metabolism 
M.tb is able to modulate its metabolism of carbon within the host phagosome, 
inducing genes involved in the β-oxidation of fatty acids and the catabolism of 
cholesterol. This shift to a lipolytic lifestyle is characterised by the up-regulation of 
multiple genes in the fadA, fadB, echA, fadE, and fadD (FACL) β-oxidation gene 
families; yielding acetyl-CoA and propionyl-CoA substrates (from even and odd chain 
number fatty acids respectively) for the TCA and methylcitrate cycles [2, 3, 10]. A 
cluster of genes (Rv3492c-Rv3574) implicated in the metabolism of cholesterol (to 
TCA intermediates) [11], many of which are regulated by kstR1/kstR2 [12], are also 
activated intracellularly; as are key genes in the anaplerotic glyoxylate cycle and 
gluconeogenesis (icl, pckA). The induction of different genes in each class of β-
oxidation enzyme has been observed after entry into human-derived [2] or murine-
derived macrophages [3] or after macrophage-like THP-1 cell infection [13], 
suggesting that the action of these degradative enzymes may be specific to 
particular fatty acids present during infection. Interestingly, the magnitude of lipid 
metabolism gene regulation also varies with the changing phagocytic environment, 
with cholesterol and β-oxidation genes up-regulated to a greater extent after infection 
of non-permissive dendritic cells compared to macrophages [2]. Genes 
representative of gluconeogenesis, β-oxidation and glyoxylate cycles have also been 
identified to be induced in bacilli isolated from murine lung [8], from human 
granulomas [6, 7] and from sputum [9], and thus represent a key metabolic 
adaptation to intracellular and in vivo life. 
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The implications of switching to fatty acids as a carbon source are not fully 
understood. However, as lipid precursor pools and toxic intermediates fluctuate as 
carbon metabolism is transformed during infection, mechanisms are required to 
utilise or remove these moieties. For example, induction of the M.tb methylcitrate 
cycle inside macrophages may be a response to the accumulation of potentially toxic 
levels of CoA-propionate [10], such a build up of propionate might result from the 
metabolism of cholesterol [14]. This changing flux of propionate intracellularly also 
drives the synthesis of methyl-branched complex lipids such as phthiocerol 
dimycocersate which incorporate methyl-malonyl precursors derived from propionate 
[14, 15]. Genes involved in the biosynthesis of several complex lipids, postulated to 
be mediators of the immune system [16], are induced after macrophage infection 
[17, 18]. This raises the possibility that switching to an alternative carbon source in 
intracellular bacilli acts as a stimulus for, or directly results in, virulence factor 
expression. 
 
Carbohydrate metabolism 
Carbohydrates are not hypothesised to be extensively metabolised during infection 
with pyruvate kinase (encoded by pykA), the major step in glycolysis and the 
metabolism of carbohydrates, repressed after monocyte-derived macrophage 
infection [2] and in sputum [9] relative to log phase axenic growth. The glycerol 
transporter encoded by glpK was also down-regulated intracellularly [2]. In contrast, 
the predicted carbohydrate transporters of unknown specificity (sugI, Rv2040c and 
Rv2041c) were induced on macrophage infection [2, 3], highlighting that the 
acquisition (or export) of carbohydrate moieties may still be important for successful 
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infection. Genes coding for the glycerol-3-phosphate transporter (ugpA/B/E) were 
also up-regulated after murine macrophage infection [3]. It has been suggested that 
carbohydrate (or amino acid) derived substrates are conserved for biosynthetic 
intent, while energy production is driven by fatty acid metabolism; reviewed in [10, 
19]. The induction of pckA, encoding the first step in the biosynthesis of sugars from 
TCA-intermediates, intracellularly [2, 3, 13] and the essentiality of this gene for 
multiple stages of murine disease [20] infers that sugars are not widely accessible 
during infection. 
 
Nutrient acquisition 
The mycobacterial phagosome has been hypothesised to be limited in nutrients 
required for bacterial growth [10, 21]. However is it difficult to interpret the 
transcriptional patterns derived from intracellular bacilli to define the complete 
nutritional status of the phagosome, with small numbers of differentially expressed 
genes identified from characterised operons, and limited overlap between infection 
models. Indeed without further investigation it is not clear whether the induction of 
genes encoding bidirectional amino acid metabolic enzymes reflects the presence 
(and opportunity to utilise) or absence (and therefore requirement to synthesise) of 
amino acid moieties. What is clear is that nutrient availability alters depending on the 
intracellular environment encountered, with genes involved in phosphate, arginine, 
histidine and tryptophan metabolism differentially expressed in bacilli isolated from 
human-derived macrophages compared to dendritic cells [2]. The induction of the 
stringent response regulator, relA, after dendritic cell relative to macrophage 
infection suggests that nutrient starvation may in part be responsible for the non-
permissive nature of the dendritic cell microenvironment [2]. The stringent response, 
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mediated by regX3, may also be triggered by phosphate limitation in murine and 
guinea pig lung [22]. The differential regulation of genes involved in nutrient 
acquisition and the transportation of amino acids has also been demonstrated in the 
human lung [6]. See [21] for an excellent review of the physiology of mycobacteria. 
 
The induction of genes coding for iron scavenging mycobactin and carboxy-
mycobactin (gene clusters mbtA-J and irtA/B, mbtL-N) were observed after murine 
and human-derived macrophage infection [2, 3], and after murine macrophage 
infection with H37Rv or H37Ra M.tb bacilli [23]. However, the up-regulation of these 
genes was not consistently detected after infection of human-derived macrophage-
like THP-1 cells [13], suggesting that the mycobacterial requirement for iron may 
shift depending on the phagosomal environment experienced. Correspondingly, 
genes encoding mycobactin were induced to a greater magnitude after IFNγ-
activation of murine macrophages [3, 24], presumably reflecting a decrease in 
available iron intracellularly. Genes representative of mycobactin were also up-
regulated in the murine lung, coinciding with the onset of the inflammatory immune 
response [4, 8]. Interestingly, M.tb bacilli may be able to utilise heme as a source of 
iron during infection, with mhuD (Rv3592) encoding a recently identified heme-
degrading enzyme [25] induced after THP-1 infection [13]. Iron limitation may also 
act as a cue for virulence factor expression or carbon storage, with an increase in 
the abundance of triacylglycerols and the production of a novel wax ester observed 
in iron-limited bacilli [26]. Iron uptake systems were not induced in bacilli extracted 
from human lung sections [6] or from sputum [9]; indicating that iron sequestration 
may not be required at every stage of M.tb infection. For a review of iron uptake in 
mycobacteria see [27]. 
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Respiratory state 
The plasticity of the M.tb respiratory chain throughout murine infection has been 
characterised by Shi and colleagues [28], who proposed that bacilli are able to 
alternate between three respiratory states in the transition from acute to chronic 
infection. During aerobic growth aa3-type oxidase (ctaBECD), cytochrome C 
reductase (qcrCAB) and type I NADH dehydrogenase (nuoA-N) systems operate, as 
oxidative stress increases (or the environment becomes microaerophilic) bacilli 
switch to an intermediate state where the less-efficient cytochrome bd oxidase 
system (cydCDBA) is activated alongside nitrate reduction (narK2, narGHJI), finally 
respiration becomes anaerobic with nitrate utilised as a final electron acceptor. 
Definitive evidence for the role of nitrate in M.tb respiration remains elusive and it 
may be that the narGHJI gene cluster is functionally important in assimilation rather 
than reduction of nitrate as a terminal electron acceptor [29]. The shift to an 
intermediary microaerophilic respiratory state is observed in intracellular bacilli with 
the down-regulation of aa3-type oxidase (ctaACD), cytochrome C reductase (qcrCA) 
and type I NADH dehydrogenase (nuoA-N) systems, and the induction of nitrate 
transporter (narK2) [2, 3]. Of note, the cytochrome bd oxidase system (cydCDBA) 
was demonstrated to be induced after human-derived macrophage infection [2], but 
repressed after murine macrophage infection [3]. Interestingly, genes involved in 
both aerobic and anaerobic respiration were expressed in human lung sections [6], 
likely reflecting the heterogeneous in vivo population of bacilli characterised. 
Transcriptional profiling of bacilli isolated from human sputa inferred the dominant 
respiratory signature to be microaerophilic or anaerobic [9]. 
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The maintenance of redox potential in intracellular bacteria is likely to be markedly 
different to log phase axenic bacilli, with multiple studies observing the activation of 
genes involved in the response to oxidative/nitrosative stresses in bacilli extracted 
from macrophage [2, 3, 13, 24] or acute murine infection [4, 30]. The complexity of 
this reprogramming is underscored by the overlapping effects that multiple 
adaptations might have on the fluctuating redox status of intracellular and in vivo 
bacilli. For example, an increase in iron uptake through the induction of 
sequestration systems in intracellular bacilli may generate reactive oxygen 
intermediates [27], while the up-regulation of the cytochrome bd oxidase system may 
actively reduce intracellular oxidative stress [28]. 
 
Immune mediator expression 
Multiple mycobacterial factors have been identified that are able to modulate host 
immune responses [31] and many genes implicated in the synthesis and transport of 
these moieties are differentially regulated through the infection process. For 
example, eis (Rv2416c) encoding a secreted protein that may remodel cytokine 
secretion [32], is induced in both murine-derived macrophages [3] and in the murine 
lung [4]. The esx gene clusters encoding type VII secretion systems have also been 
demonstrated to be induced during murine macrophage infection [33] and in the 
murine lung [34]. It is likely that expression of these products, responsible for the 
export of antigenic proteins (exemplified by esxA and esxB coding for ESAT-6 and 
CFP-10) that are involved in membrane lysis [35], is carefully controlled by spatial 
and temporal determinants. Thus, esx genes have also been observed to be 
repressed after macrophage uptake [2, 3, 13]. Furthermore, representatives of this 
gene family were also differentially expressed between virulent (H37Rv) and 
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attenuated (H37Ra) M.tb strains after macrophage infection, highlighting the central 
role these effector molecules may play in pathogenicity [23]. The transcription of a 
second family of immunogenic proteins encoded by the PE/PPE genes, a subset of 
which are associated with ESX secretion systems, are also regulated by multiple 
environmental signals [36]. Many PE/PPE genes, with manifold hypothesised roles in 
mediating host-pathogen interactions, have been identified to be induced (11 [13]; 18 
[2]; 21 [3]) or repressed (13 [13]; 10 [2]; 4 [3]) after macrophage infection. The 
differential regulation of these putative virulence factors mediated by diverse stimuli 
spotlights this family as an exciting prospect for future research. 
 
Other transporters that may influence host-pathogen interplay are encoded by the 
mce1-4 (mammalian cell entry) operons. These ABC uptake systems likely involved 
in the transportation of lipids, the abrogation of which dramatically affects virulence in 
mice and non-human primates (reviewed in [37]), are also differentially expressed 
after macrophage infection. The mce1 (and mce4) operons were repressed after 
phagocytosis, whilst mce2 and mce3 operons were induced [2, 3]. The differential 
regulation of lipid transporters together with the induction of genes involved in the 
biosynthesis of M.tb complex lipids after macrophage infection [2, 17, 18] highlights a 
role for lipid factors in regulating host-pathogen interactions. These lipid moieties 
may regulate the hydrophobicity of the mycobacterial cell wall during infection, act as 
effector molecules modulating the host immune response, and/or be synthesised 
during intracellular growth to alleviate the toxic effects of fatty acid metabolism 
intermediates [10, 14, 15, 16, 38]. 
 
Growth rate 
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Genes encoding M.tb ribosomal proteins (rpl, rps and rpm gene families) are 
repressed after macrophage infection in comparison to log phase axenic growth [2, 
3]. This down-regulation of genes involved so intimately in microbial protein 
translation correlates with an initial slowing of M.tb multiplication after phagocyte 
infection. These changes are also accompanied by a repression of genes encoding 
ATP synthase subunits (atpA-H), which may reflect a changing energy requirement 
of intracellular bacilli. Furthermore, ribosomal genes are repressed with time after 
dendritic cell compared to macrophage infection; as the dendritic cell 
microenvironment becomes non-permissive for growth relative to the macrophage, 
where bacilli are able to replicate [2]. Ribosomal genes were also expressed at a 
lower level after IFNγ stimulation of murine macrophages correlating with an 
increasingly cidal intracellular niche [3]. This slow-growth signature has also been 
identified in bacilli extracted from sputum, alongside induction of genes involved in 
lipid metabolism [9]. Chemostat modelling of the transcriptomic changes associated 
with fast and slow mycobacterial growth revealed significant overlaps with gene 
expression patterns derived from intracellular bacilli; thus growth rate may influence 
the expression of multiple virulence genes and might therefore be classified as a 
virulence factor itself [39]. Mycobacterial growth is affected by numerous constraints 
and stresses, many of which are likely to fluctuate during intracellular and in vivo life, 
unravelling this relationship between physiological state, growth rate and virulence 
factor expression will expose key mycobacterial survival strategies. 
 
Regulation of gene expression 
Thirteen sigma factors have been identified in M.tb, reviewed in [40], many of which 
have been demonstrated to be differentially regulated in the intracellular 
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environment, sigA, sigB, sigC, sigD, sigE, sigG, sigH, sigJ, sigL [2, 3, 18, 41], or after 
murine infection, sigB, sigC, sigH, sigK [4, 42]. The M.tb genome also includes 7 
transcriptional regulators (whiB1-7) with homology to the Streptomyces WhiB 
sporulation factor. Of these, whiB3 was up-regulated in the intracellular niche [13, 
33], as was whiB4 [24], whiB6 [2] and whiB7 [33]; while whiB2 was down-regulated 
after macrophage infection [2, 13]. Additionally, the transcriptional regulators, ethR, 
ideR, kstR and relA have been identified as up-regulated intracellularly, and likely 
play important roles [2, 3, 12, 13].  
 
M.tb utilises a number of the 11 two-component systems identified in the genome to 
sense and respond to the intracellular environment, devRS (dosRS), kdpE, mprA, 
mtrA, phoP, prrA, regX3, and trcR [2, 3, 13, 43]. Two of these regulatory systems, 
phoPR and dosRST, have been particularly well studied and exemplify the range of 
adaptations demanded of bacilli during infection. The phoPR two component system 
is required for virulence in macrophage and murine models of infection, regulating 
genes involved in complex lipid metabolism and ESX effector molecule expression; 
summarised in [44]. A point mutation in phoP may account for attenuation of H37Ra 
compared to H37Rv M.tb [45]. Moreover, comparison of the intracellular 
transcriptomes of H37Ra and H37Rv revealed differential regulation of these methyl-
branched lipids and ESX-related genes, further highlighting the significance of this 
regulator in managing the macrophage environment [23]. Of additional importance to 
the site-specific expression of phoP-mediated virulence determinants, is the 
observation that the induction of phoP-regulated genes may be triggered by the 
slight acid environment (pH ~6.4) of the murine macrophage phagosome [33]. 
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The devRST (dosRST) transcriptional regulator controls the expression of 
approximately 50 genes [46]. This regulon has been identified to be induced after 
macrophage infection [2, 3, 13, 33]; with an increase in magnitude of dosR regulon 
expression in IFNγ-activated murine macrophages dependent on a functioning 
murine NOS2 gene [3], and over time after infection of non-permissive monocyte-
derived dendritic cells relative to macrophages [2]. The dosR regulon was also up-
regulated in bacilli isolated from artificial murine granulomas [42] and the murine lung 
following induction of the adaptive immune response [47]. Genes representative of 
the dosR regulon have also been identified to be induced in the human lung [7, 8], 
and a dosR signature is present in bacilli extracted from human sputa [9]. Therefore, 
genes regulated by dosR appear to be functionally significant in the adaption of M.tb 
bacilli to multiple stages of infection. Environmental stimuli that result in dosR 
induction are varied with hypoxia, nitric oxide, carbon monoxide, SDS, low pH and 
hydrogen peroxide implicated; reviewed recently [48]. It should be noted that 
although the dosR regulon is associated with a slowing of mycobacterial growth in 
many experimental models, this is not always the case with the dosR regulon 
induced in rapidly-replicating bacilli in a low-oxygen chemostat model (0.2% 
dissolved O2 tension) [49]. The function of the dosR-mediated response remains to 
be fully elucidated; however it is probably important in the adaptation of M.tb to 
changes in redox status throughout the infectious process. Understanding the 
environmental cues that are important during infection, and the regulatory cascades 
that are triggered, will precipitate novel intervention strategies for combating 
M.tuberculosis disease. 
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Conclusions  
Insight into M.tuberculosis transcriptional responses that influence pathogenicity 
mostly comes from the comparison of intracellular or in vivo mycobacterial 
populations to log phase bacilli. This successful strategy, which enables 
transcriptional signatures to be easily contrasted, relies on a very well defined but 
ultimately contrived axenic M.tb growth state as a comparator condition. An 
alternative approach directly comparing M.tb intracellular transcriptomes after 
infection of different phagocytic cells [2], or after macrophage activation [3] reveals 
more subtle changes in gene expression as the microenvironment encountered by 
infecting bacilli diverges over time. Moreover studies contrasting the RNA signatures 
reflecting the fate of attenuated and virulent mycobacterial strains [23, 33], or the 
transcriptional modifications of bacilli in vivo after onset of the inflammatory immune 
response [4, 47] will begin to characterise what adaptations are necessary for bacilli 
to continue to survive the slings and arrows of outrageous infection. This work, 
aimed at exploring the changing physiological state of M.tb during disease, may also 
be used in conjunction with gene essentiality studies to identify tractable pathways 
for novel drug development targeting key in vivo populations of bacilli. 
 
A major benefit of these global profiling datasets is the ability to attribute predicted 
action to genes of unknown function using gene regulatory or protein network 
modelling [24, 50]. Such interaction networks, together with metabolic models of M.tb 
[51], will be required to map and digest the huge quantity of mRNA abundance data 
generated from microarray and sequencing projects. Finally, in vitro transcriptional 
profiling of mycobacterial responses to selected stresses, metabolites and growth 
constraints in controlled settings will allow the multi-factorial signatures captured in 
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vivo to be dissected [3, 9, 12, 22, 26, 33, 39, 44, 49, 52, 53]. Thus, providing an 
interpretive framework of transcriptional patterns delineating complex M.tb 
responses and contributing to the development of in vitro models (applicable to 
whole cell screening) representing specific populations of bacilli that exist during 
natural infection. 
 
Transcriptional profiling M.tuberculosis bacilli isolated from intracellular and in vivo 
infection settings has defined a set of core adaptations, such as the metabolism of 
lipids as a carbon source and shifting respiratory state, which are common to 
multiple (but most likely not all) stages of M.tb infection. As new technologies are 
developed for identifying, isolating and mRNA profiling distinct M.tb populations 
during infection [54], the contrasting characteristics of these bacilli and the niches 
they occupy will help to shape novel anti-mycobacterial drug and vaccine 
development. 
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Figure 1 
The intracellular and in vivo populations of M.tuberculosis captured by transcriptional 
profiling. Each model examining the in vivo lifestyle of M.tb samples different 
populations of bacilli that may exist in diverse physiological states. Intracellular 
models of infection have characterised mycobacterial responses to environments 
both permissive and non-permissive for growth [2, 3]. Extracellular bacilli in vivo 
have not been profiled exclusively; however this population likely contributes to the 
gene expression patterns derived from selected regions of infected human lung [6] 
and from murine lung harvested during acute infection [4]. Sputa collected from 
patients may contain bacilli representative of all these populations together with 
bacilli adapted for successful transmission [9]. 
 
Figure 2 
The major themes summarising the reprogramming of the M.tuberculosis 
transcriptome in response to the intracellular or in vivo environments encountered 
during infection; based extensively on gene expression signatures derived from 
macrophage infection models. Representative gene families are marked in each 
class. The stimuli, signalling mechanisms and regulatory networks responsible for 
this remodelling require further elucidation. In addition, there is likely to be significant 
interplay between these transcriptional adaptations, influencing multiple facets of 
M.tb physiology throughout disease. 
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